Non-human Primate Total-body Irradiation Model with Limited and Full Medical Supportive Care Including Filgrastim for Biodosimetry and Injury Assessment

Natalia I. Ossetrova, William F. Blakely, Vitaly Nagy, Camille F. McGann, Patrick H. Ney, Christine L. Christensen, Amory Koch, Jatinder Gulani, George B. Sigal, Eli N. Glezer,

Radiation Protection Dosimetry · 2016 · 20 citations · 42 references

DOIFull text

Open access

Concepts

Abstract

An assessment of multiple biomarkers from radiation casualties undergoing limited-or full-supportive care including treatment with filgrastim is critical to develop rapid and effective diagnostic triage strategies. The efficacy of filgrastim with fullsupportive care was compared with results with limited-supportive care by analyzing survival, necropsy, histopathology and serial blood samples for hematological, serum chemistry and protein profiles in a non-human primate (Macaca mulatta, male and female) model during 60-d post-monitoring period following sham-and total-body irradiation with 6.5 Gy 60 Co gamma-rays at 0.6 Gy min -1 . Filgrastim (10 g kg -1 ) was administered beginning on Day 1 post-exposure and continued daily until neutrophil counts were 2,000 L -1 for two consecutive days. Filgrastim and full-supportive care significantly decreased the pancytopenia duration and resulted in improved animal survival and recovery compared to animals with a limited-supportive care. These findings also identified and validated a multiparametric biomarker panel to support radiation diagnostic device development.

References

42